(editor's note: During the recent BIO 2016 conference and exhibition in San Francisco we talked with Chris Gardner and Jeremy Grushcow from Sequence Bio about the 100k Genome Research Project.)
Media Release, August 10, 2016, Twillingate, Newfoundland and Labrador -
Neala Quigley, Director of Community Engagement of Sequence Bio, is proud to announce that Dr. Mohamed Ravalia and the Notre Dame Memorial Health Centre team in Twillingate, Newfoundland and Labrador, have come onboard as the first investigator site for the pilot phase of the Newfoundland and Labrador 100k Genome Research Project.
Sequence Bio is a data-driven biotechnology company based in St. John’s, Newfoundland and Labrador, that is leading a 100,000 person genome research project (the 100k Genome Research Project). This project will engage people from across Newfoundland and Labrador and is a unique and remarkable opportunity to transform drug discovery by using data compiled from our unique genetic makeup to find new cures and develop better, safer medicines - all while returning benefits back to patients and the healthcare system.
In the role as investigator, Dr. Ravalia and the physician team at the Notre Dame Memorial Health Centre will invite patients to enrol in the pilot phase of the 100k Genome Research Project, provide feedback on the study process, and aid in the development of a continuing education program to increase genomics literacy. The physician team led by Dr. Ravalia is also composed of Dr. Andrew Hunt, Dr. Chad Petten, Dr. Jason Mackey and Dr. Shauna Peddle.
Neala Quigley stated, “We couldn’t be more proud to have Dr. Ravalia and his team on board. He has been recognized as one of the best physicians in the country and brings a forward-thinking and patient-first mindset to everything he does. By participating in this project, the Notre Dame Memorial Health Centre team, under Dr. Ravalia’s innovative leadership, will help us deliver better care and healthcare outcomes to Newfoundland and Labrador.”
In Twillingate today, Dr. Ravalia noted the importance of this project to the province, “This community project will directly impact the people of Newfoundland and Labrador. By changing how we look at healthcare and engaging in this study, the people of this province will be on the forefront of cutting edge initiatives and technologies that have the potential to realize significant clinical benefits.”
About Dr. Mohamed Ravalia and the Notre Dame Memorial Health Centre
Dr. Mohamed Ravalia has been a physician in rural Newfoundland and Labrador for 32 years and also serves as Associate Professor and Assistant Dean of the Faculty of Medicine’s Rural Medical Education Network. A leader in his field, he was awarded the Order of Canada in 2015 for his contributions to rural medicine as a family physician, mentor and community leader. Dr. Ravalia was also named family physician of the year by the College of Family Physicians of Canada and was presented with the Queen’s Diamond Jubilee Medal.
About Sequence Bio
Sequence Bio is a data-driven biotechnology company in Newfoundland and Labrador, Canada leading a 100,000 person genome project. This project will transform drug discovery and enable better healthcare outcomes through the use of well-characterized patient data integrated with multi ‘omics information. Sequence Bio is committed to working with participants, collaborators and partners to enable innovation that enhances the lives of patients, families and communities in Newfoundland and Labrador and around the world. Please visit www.SequenceBio.co
for additional corporate, investor and participant information.
VP Public Affairs & Communications